Submissions are supported by data from the Phase 3 Viti-Up clinical studies demonstrating upadacitinib achieved the co-primary endpoints of at least a 50% improvement ...

Fractyl Health has reported positive six-month randomized results from the REMAIN-1 Midpoint Cohort, a blinded, sham-controlled study of its Revita procedure for weight maintenance after GLP-1 drug ...

Background: Previous reports have suggested that the incidence of psychotic disorders has either been stable or decreasing ...

Microsize brings over thirty years of expertise in specialized particle size engineering for the pharmaceutical industry, from pre-clinical development to full-scale GMP commercial manufacturing. ESTE ...

Objectives Female sex and anticitrullinated protein antibodies (ACPA) are associated with higher disease activity in ...